Connection

Perry Molinoff to Humans

This is a "connection" page, showing publications Perry Molinoff has written about Humans.
Connection Strength

0.130
  1. Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra. Int J Impot Res. 2004 Apr; 16(2):135-42.
    View in: PubMed
    Score: 0.009
  2. Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction. Int J Impot Res. 2004 Feb; 16(1):51-9.
    View in: PubMed
    Score: 0.009
  3. PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Ann N Y Acad Sci. 2003 Jun; 994:96-102.
    View in: PubMed
    Score: 0.008
  4. Regulation of D2 and D3 receptors in transfected cells by agonists and antagonists. Adv Pharmacol. 1998; 42:443-6.
    View in: PubMed
    Score: 0.006
  5. Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells. Mol Pharmacol. 1995 Nov; 48(5):956-64.
    View in: PubMed
    Score: 0.005
  6. Lack of discrimination by agonists for D2 and D3 dopamine receptors. Neuropsychopharmacology. 1995 Jul; 12(4):335-45.
    View in: PubMed
    Score: 0.005
  7. Mechanisms of up-regulation of D2L dopamine receptors by agonists and antagonists in transfected HEK-293 cells. J Pharmacol Exp Ther. 1994 Dec; 271(3):1574-82.
    View in: PubMed
    Score: 0.005
  8. Characterization of [125I](R)-trans-7-hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino] tetralin binding to dopamine D3 receptors in rat olfactory tubercle. J Pharmacol Exp Ther. 1994 Feb; 268(2):935-42.
    View in: PubMed
    Score: 0.004
  9. Molecular pharmacology of NMDA receptors: modulatory role of NR2 subunits. Prog Brain Res. 1994; 100:39-45.
    View in: PubMed
    Score: 0.004
  10. Paradoxical regulation of dopamine receptors in transfected 293 cells. Mol Pharmacol. 1993 Aug; 44(2):371-9.
    View in: PubMed
    Score: 0.004
  11. Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides. Mol Pharmacol. 1993 May; 43(5):666-76.
    View in: PubMed
    Score: 0.004
  12. Expression and characterization of the rat D3 dopamine receptor: pharmacologic properties and development of antibodies. J Pharmacol Exp Ther. 1993 Feb; 264(2):1002-11.
    View in: PubMed
    Score: 0.004
  13. Evolving properties of beta-adrenergic receptor antagonists. Pharmacotherapy. 1992; 12(2):144-53.
    View in: PubMed
    Score: 0.004
  14. Developing treatments for female sexual dysfunction. Clin Pharmacol Ther. 2011 Jan; 89(1):137-41.
    View in: PubMed
    Score: 0.003
  15. Effect of exercise duration on density and coupling of beta-adrenergic receptors on human mononuclear cells. J Appl Physiol (1985). 1989 Mar; 66(3):1494-500.
    View in: PubMed
    Score: 0.003
  16. Mechanisms of downregulation of beta-adrenergic receptors: perspective on the role of beta-adrenergic receptors in congestive heart failure. J Cardiovasc Pharmacol. 1989; 14 Suppl 5:S13-8.
    View in: PubMed
    Score: 0.003
  17. Characterization of binding sites for 3H-spiroperidol in human retina. Invest Ophthalmol Vis Sci. 1988 May; 29(5):687-94.
    View in: PubMed
    Score: 0.003
  18. Distribution and properties of beta-adrenergic receptors in human iris-ciliary body. Invest Ophthalmol Vis Sci. 1987 Mar; 28(3):420-30.
    View in: PubMed
    Score: 0.003
  19. Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes. J Pharmacol Exp Ther. 1986 Oct; 239(1):117-23.
    View in: PubMed
    Score: 0.003
  20. Quantitative analysis of the selectivity of radioligands for subtypes of beta adrenergic receptors. J Pharmacol Exp Ther. 1986 Jul; 238(1):46-53.
    View in: PubMed
    Score: 0.003
  21. Effects of chronic administration of agonists and antagonists on the density of beta-adrenergic receptors. Am J Cardiol. 1986 Apr 25; 57(12):17F-22F.
    View in: PubMed
    Score: 0.003
  22. Coexistence of beta-1 and beta-2 adrenergic receptors in the human heart: effects of treatment with receptor antagonists or calcium entry blockers. J Pharmacol Exp Ther. 1985 Sep; 234(3):561-8.
    View in: PubMed
    Score: 0.002
  23. In vitro interactions of agonists and antagonists with beta-adrenergic receptors. Biochem Pharmacol. 1984 Mar 15; 33(6):869-75.
    View in: PubMed
    Score: 0.002
  24. Alpha- and beta-adrenergic receptor subtypes properties, distribution and regulation. Drugs. 1984; 28 Suppl 2:1-15.
    View in: PubMed
    Score: 0.002
  25. Decreased beta adrenergic receptor density on human lymphocytes after chronic treatment with agonists. J Pharmacol Exp Ther. 1983 Jan; 224(1):1-6.
    View in: PubMed
    Score: 0.002
  26. Effects of drugs on beta-adrenergic receptors on human lymphocytes. J Cardiovasc Pharmacol. 1983; 5 Suppl 1:S63-7.
    View in: PubMed
    Score: 0.002
  27. Effects of pindolol and propranolol on beta-adrenergic receptors on human lymphocytes. Br J Clin Pharmacol. 1982; 13(Suppl 2):365S.
    View in: PubMed
    Score: 0.002
  28. Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat Med. 2001 Apr; 7(4):471-7.
    View in: PubMed
    Score: 0.002
  29. Beta-adrenergic receptor subtypes: properties, distribution, and regulation. Annu Rev Neurosci. 1981; 4:419-61.
    View in: PubMed
    Score: 0.002
  30. Effects of ethanol administration and withdrawal on neurotransmitter receptor systems in C57 mice. J Pharmacol Exp Ther. 1980 Jun; 213(3):491-6.
    View in: PubMed
    Score: 0.002
  31. Classification and quantitation of beta-adrenergic receptor subtypes. Biochem Pharmacol. 1980 May 15; 29(10):1317-23.
    View in: PubMed
    Score: 0.002
  32. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration. J Clin Invest. 1980 May; 65(5):949-57.
    View in: PubMed
    Score: 0.002
  33. Brain neurotransmitter receptor systems in alcohol treated mice and in mice genetically selected for differences in sensitivity to alcohol. Adv Exp Med Biol. 1980; 132:787-95.
    View in: PubMed
    Score: 0.002
  34. Increased human lymphocyte beta-adrenergic receptor density following chronic propranolol treatment. Proc West Pharmacol Soc. 1979; 22:175-6.
    View in: PubMed
    Score: 0.002
  35. 5-hydroxytryptamine1A receptor-mediated increases in receptor expression and activation of nuclear factor-kappaB in transfected Chinese hamster ovary cells. Mol Pharmacol. 1997 Aug; 52(2):221-6.
    View in: PubMed
    Score: 0.001
  36. Occurrence, transport, and storage of octopamine in human thrombocytes. Clin Pharmacol Ther. 1975 Nov; 18(5 Pt 1):587-93.
    View in: PubMed
    Score: 0.001
  37. Expression of the human 5-hydroxytryptamine1A receptor in Sf9 cells. Reconstitution of a coupled phenotype by co-expression of mammalian G protein subunits. J Biol Chem. 1995 Aug 04; 270(31):18691-9.
    View in: PubMed
    Score: 0.001
  38. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev. 1994 Jun; 46(2):121-36.
    View in: PubMed
    Score: 0.001
  39. The regulation of the noradrenergic neuron. J Psychiatr Res. 1974; 11:339-45.
    View in: PubMed
    Score: 0.001
  40. Subtypes of serotonin receptors and anxiolytic drugs: model systems for the study of 5-HT receptors. Clin Neuropharmacol. 1992; 15 Suppl 1 Pt A:531A-532A.
    View in: PubMed
    Score: 0.001
  41. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients. Circulation. 1989 Oct; 80(4):903-14.
    View in: PubMed
    Score: 0.001
  42. New form of pseudohypoparathyroidism with abnormal catalytic adenylate cyclase. Am J Physiol. 1989 Aug; 257(2 Pt 1):E277-83.
    View in: PubMed
    Score: 0.001
  43. Characterization of lymphocyte beta-adrenergic receptors at rest and during exercise in ambulatory patients with chronic congestive heart failure. Am J Cardiol. 1989 Feb 01; 63(5):307-12.
    View in: PubMed
    Score: 0.001
  44. Characterization of beta-adrenergic receptors in cultured human trabecular cells and in human trabecular meshwork. Invest Ophthalmol Vis Sci. 1989 Jan; 30(1):51-7.
    View in: PubMed
    Score: 0.001
  45. Acute and long-term effects of acebutolol on systemic and renal hemodynamics, body fluid volumes, catecholamines, active renin, aldosterone, and lymphocyte beta-adrenoceptor density. J Cardiovasc Pharmacol. 1988 Apr; 11(4):413-23.
    View in: PubMed
    Score: 0.001
  46. Role of beta-adrenergic receptors in catecholamine-induced desensitization of adenylate cyclase in human astrocytoma cells. J Biol Chem. 1978 Mar 10; 253(5):1472-80.
    View in: PubMed
    Score: 0.000
  47. Competitive effects of hypokalemia and volume depletion on plasma renin activity, aldosterone and catecholamine concentrations in hemodialysis patients. Kidney Int. 1977 Oct; 12(4):279-84.
    View in: PubMed
    Score: 0.000
  48. Electrophoretic properties of dopamine -hydroxylase in several tissues from three species. Mol Pharmacol. 1972 Jan; 8(1):50-8.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.